Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Andrew David Shore has worked on the following 22 EPO patent applications which have been published in the last five years:

EP12718651

DIHYDROQUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4709, A61P 35/00, C07D 401/10
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Agent:
Andrew David Shore, GlaxoSmithKline Intellectual Property Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12716378

TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4706, A61K 31/4709, A61P 29/00, A61P 35/00, C07D 215/42, C07D 215/44, C07D 401/12
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Agent:
Andrew David Shore, GlaxoSmithKline Intellectual Property Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12718620

TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4706, A61K 31/4709, A61P 29/00, A61P 35/00, C07D 215/44, C07D 401/04, C07D 401/12, C07D 401/14
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Agent:
Andrew David Shore, GlaxoSmithKline Intellectual Property Limited
Status:
PATENT GRANTED
EP13192666

Benzodiazepine bromodomain inhibitor

IPC classification:
A61K 31/55, A61P 35/00, A61P 43/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12748028

4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

IPC classification:
A61K 31/4745, A61P 29/00, A61P 37/00, C07D 471/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
PATENT GRANTED
EP12761738

MORPHOLINO SUBSTITUTED UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS

IPC classification:
A61K 31/53, A61P 35/00, A61P 37/02, A61P 37/04, A61P 37/06, A61P 37/08, C07D 251/22, C07D 401/12, C07D 407/12, C07D 413/04
Applicant:
Cellzome Ltd
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
PATENT GRANTED
EP12769098

MORPHOLINO SUBSTITUTED BICYCLIC PYRIMIDINE UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS

IPC classification:
A61K 31/519, C07D 417/02
Applicant:
Cellzome Ltd
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703017

PI3K INHIBITORS FOR TREATING COUGH

IPC classification:
A61K 31/501, A61K 31/5377, A61P 11/14
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826498

BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS

IPC classification:
A61K 31/69, A61P 31/14
Applicant:
Glaxo Group Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
PATENT GRANTED
EP13737782

NICOTINAMIDE DERIVATE IN THE TREATMENT OF ACUTE CORONARY SYNDROME

IPC classification:
A61K 9/00, A61K 31/455, A61P 9/10
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP13750830

BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCER

IPC classification:
A61K 31/5517, A61P 35/00
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14735983

LOSMAPIMOD FOR USE IN TREATING GLOMERULAR DISEASE

IPC classification:
A61K 31/455, A61K 45/06, A61P 13/12
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11725769

BENZOTRIAZOLODIAZEPINE COMPOUNDS INHIBITORS OF BROMODOMAINS

IPC classification:
A61K 31/5517, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Agent:
Andrew David Shore, GlaxoSmithKline Intellectual Property Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16150637

NOVEL BENZODIAZEPINE COMPOUND

IPC classification:
A61K 31/55, A61K 31/5517, A61P 35/00, A61P 43/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP16152464

BENZODIAZEPINE BROMODOMAIN INHIBITOR

IPC classification:
A61K 31/55, A61P 35/00, A61P 43/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15710919

METHODS OF TREATING CANCER PATIENTS RESPONDING TO EZH2 INHIBITOR GSK126

IPC classification:
A61K 31/00, G01N 33/574
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15715424

ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS

IPC classification:
A61K 45/06, A61P 35/00, C07D 471/14
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16192662

4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

IPC classification:
A61K 31/4745, A61P 29/00, A61P 37/00, C07D 471/04
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16197070

TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4706, A61K 31/4709, A61P 29/00, A61P 35/00, C07D 215/44, C07D 401/04, C07D 401/12, C07D 401/14
Applicant:
GlaxoSmithKline LLC
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15760461

TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4709, A61P 29/00, A61P 31/12, A61P 35/00, C07D 401/12, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
Request for examination was made
EP16195408

BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS

IPC classification:
A61K 31/34, A61K 31/343, A61K 31/69, A61P 31/14, C07D 307/85, C07F 5/04
Applicant:
Glaxo Group Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
Request for examination was made
EP16191843

PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM

IPC classification:
A61K 9/00, A61K 31/7016, A61K 31/715, C07H 3/00, C13K 5/00
Applicant:
Glaxo Group Limited
Agent:
Andrew David Shore, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature